Keywords: Obesity, Glucagon-like-peptide-1 receptor agonists, Empathy, Communication, Drug-safety Introduction It is common for patients to express concern about starting glucagon-like-peptide-1 receptor agonists (GLP-1RA), worrying that these medications are too new or that their long-term effects are unknown
If left unchecked, lipid peroxidation destroys the structural integrity of the mitochondria and triggers a highly inflammatory form of programmed cell death known as ferroptosis, a mechanism heavily implicated in the pathophysiology of ME/CFS
NAD+ is also important for sirtuin regulation (DNA repair, inflammation processes, and fat metabolism)
How AOD-9604 Works (in Brief) AOD-9604 was engineered from the C-terminal segment of human growth hormone (amino acids 177191) the portion thought to influence fat metabolism. In preclinical models, this fragment supported fat oxidation and lipid mobilization without the broader hormonal effects of full-length hGH. Because it does not activate the traditional hGH receptor, its fat-metabolism effects are considered indirect and receptor-independent. Discovery & Research Milestones Originally developed in the 1990s as a potential anti-obesity drug
